No higher risk of rheumatic and musculoskeletal disease flares seen after COVID-19 vaccinationAugust 4, 2021COVID-19 UpdatesVaccinesRheumatology
FDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 yearsAugust 2, 2021Rheumatology
COVID-19 vaccination does not increase risk of flare in patients with lupusJuly 27, 2021COVID-19 UpdatesRheumatologyVaccines
Autoinflammatory diseases ‘not so rare after all,’ expert saysJuly 22, 2021PediatricsDermatologyRheumatologyRare Diseases
COVID-19 vaccine hesitancy still weighs heavy for some rheumatic disease patientsJuly 21, 2021COVID-19 UpdatesRheumatologyVaccines
FDA approves intravenous immunoglobulin for dermatomyositisJuly 21, 2021RheumatologyDermatologyRare Diseases
New ACR guidance recommends COVID-19 vaccination in RMD patientsJune 24, 2021COVID-19 UpdatesRheumatology
An otherwise healthy 1-month-old female presents with lesions on the face, scalp, and chestJune 15, 2021DermatologyRheumatologyPediatrics
TNF inhibitors have delayed effect on spondyloarthritis radiographic progressionJune 11, 2021Rheumatology
Novel study links air pollution to increased risk of rheumatoid arthritis flaresJune 8, 2021PulmonologyRheumatology
Patients with RA on rituximab at risk for worse COVID-19 outcomesJune 8, 2021COVID-19 UpdatesRheumatology
Osteoporosis linked to increased risk of hearing lossJune 8, 2021Women's HealthRheumatologyEndocrinology
